BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 849883)

  • 1. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 5. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of an in vitro microcytotoxicity test to assess human tumor-specific cell-mediated immunity and its serum-mediated abrogation.
    Levy NL
    Natl Cancer Inst Monogr; 1973 Jun; 37():85-92. PubMed ID: 4576707
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific cellular immunity.
    Cohen AM; Burdick JF; Ketcham AS
    J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of tumour associated antigens on human colonic carcinomata.
    Embleton MJ
    Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral and immunologic studies of human neoplasms.
    Malmgren RA; Morton DL
    Pathobiol Annu; 1971; 1():63-81. PubMed ID: 4359566
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardization of microcytotoxicity assay for cell-mediated immunity.
    O'Toole C
    Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
    Perlmann P; O'Toole C; Unsgaard B
    Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 19. Murine bladder tumors as models for human tumor immunity.
    Hellström I; Hellström KE
    Natl Cancer Inst Monogr; 1972 Dec; 35():125-7. PubMed ID: 4659043
    [No Abstract]   [Full Text] [Related]  

  • 20. Some immunological considerations relevant to the study of human bladder cancer.
    Bean MA
    Cancer Res; 1977 Aug; 37(8 Pt 2):2879-84. PubMed ID: 326394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.